ArticleEmerging infectious diseases2020
Blastomycosis in Minnesota, USA, 1999-2018.
Article in Emerging infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 36 citations in OpenAlex.
- Home Renovation Gone Wrong: A Curious Case of Disseminated Blastomycosis.Journal of Brown hospital medicine · 2026Article
- Updating the Epidemiology of Blastomycosis and Histoplasmosis in the United States, Using National Electronic Health Record Data, 2013-2023.The Journal of infectious diseases · 2025Article
- Endemic Mycoses for Pulmonary Clinicians: From Nodules to ARDS.CHEST pulmonary · 2025Review
- Diagnosing Blastomycosis: A Review of Laboratory Methods and Clinical Utility.Journal of fungi (Basel, Switzerland) · 2025Review
- Exploring Stakeholder Perceptions about Using Artificial Intelligence for the Diagnosis of Rare and Atypical Infections.Applied clinical informatics · 2025Article
- Severe Pulmonary Blastomycosis in a Young Adult: Probable Role of E-Cigarette Use in Immunosuppression.Case reports in medicine · 2025Article
- Perspectives on blastomycosis in Canada in the face of climate change.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2024Article
- Testing for Blastomycosis, Coccidioidomycosis, and Histoplasmosis at a Major Commercial Laboratory, United States, 2019-2024.Open forum infectious diseases · 2024Article
- Using Insurance Claims Data to Estimate Blastomycosis Incidence, Vermont, USA, 2011-2020.Emerging infectious diseases · 2024Article
- Blastomycosis-Associated Hospitalizations, United States, 2010-2020.Journal of fungi (Basel, Switzerland) · 2023Article
- Diagnostic delay in pulmonary blastomycosis: a case series reflecting a referral center experience.Infection · 2023Article
- Vaccines to Prevent Coccidioidomycosis: A Gene-Deletion Mutant of Coccidioides Posadasii as a Viable Candidate for Human Trials.Journal of fungi (Basel, Switzerland) · 2022Review
- Article
- Changing Patterns of Disease Severity in Blastomyces dermatitidis Infection, Quebec, Canada.Emerging infectious diseases · 2021Article
- Diagnostic Methods and Risk Factors for Severe Disease and Mortality in Blastomycosis: A Retrospective Cohort Study.Journal of fungi (Basel, Switzerland) · 2021Article
- Recent Trends in the Epidemiology of Fungal Infections.Infectious disease clinics of North America · 2021Review
- Blastomycosis Surveillance in 5 States, United States, 1987-2018.Emerging infectious diseases · 2021Review
- Analysis and modeling ofApplied and environmental microbiology · 2021Article
- Endemic and Other Dimorphic Mycoses in The Americas.Journal of fungi (Basel, Switzerland) · 2021Review
- Subcutaneous Mycoses in Travelers.Current tropical medicine reports · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
Abstract
Blastomycosis is a systemic disease caused by Blastomyces spp. fungi. To determine its epidemiology in blastomycosis-endemic Minnesota, USA, we evaluated all cases reported to public health officials during 1999-2018. We focused on time to diagnosis, exposure activities, and exposure location. A total of 671 cases and a median of 34 cases/year were reported. Median time to diagnosis was 31 days; 61% of patients were not tested for blastomycosis until they were hospitalized. The case-fatality rate was 10%, and patients who died were 5.3 times more likely to have a concurrent medical condition. Outdoor activities and soil exposure were reported by many patients, but no specific activity or exposure was common to most. Almost one third of patients were probably exposed in geographic areas other than their home county. Providers should consider alternative etiologies for patients with pneumonia not responding to antibacterial treatment, and public health officials should increase awareness in blastomycosis-endemic areas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.